AIHTA - Publications - Search - Darolutamide (Nubeqa®) in nonmetastatic, castration-resistant prostate cancer (nmCRPC)

Grössmann, N. (2020): Darolutamide (Nubeqa®) in nonmetastatic, castration-resistant prostate cancer (nmCRPC). Oncology Fact Sheet Nr. 2.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
65Kb

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
WJ Urogenital system > WJ 700-875 Male genitalia
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:English
Series Name:Oncology Fact Sheet Nr. 2
Deposited on:29 Mar 2020 04:22
Last Modified:02 Jun 2020 18:36

Repository Staff Only: item control page